NFKB1 and neoplasm: The sustained activation of the PI3K/AKT-NF-κB axis upregulated P-glycoprotein expression and accelerated cyclin D-mediated cell cycle progression, leading to increased tumor aggressiveness and resistance to Cisplatin and Paclitaxel [43]​.